359 related articles for article (PubMed ID: 26918035)
81. Vitamin D Receptor Polymorphism and Breast Cancer Risk: A Meta-Analysis.
Lu D; Jing L; Zhang S
Medicine (Baltimore); 2016 May; 95(18):e3535. PubMed ID: 27149457
[TBL] [Abstract][Full Text] [Related]
82. Associations of intakes of magnesium and calcium and survival among women with breast cancer: results from Western New York Exposures and Breast Cancer (WEB) Study.
Tao MH; Dai Q; Millen AE; Nie J; Edge SB; Trevisan M; Shields PG; Freudenheim JL
Am J Cancer Res; 2016; 6(1):105-13. PubMed ID: 27073728
[TBL] [Abstract][Full Text] [Related]
83. MicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate Cancer.
Bertoli G; Cava C; Castiglioni I
Int J Mol Sci; 2016 Mar; 17(3):421. PubMed ID: 27011184
[TBL] [Abstract][Full Text] [Related]
84. Homocysteine, antioxidant vitamins and lipids as biomarkers of neurodegeneration in Alzheimer's disease versus non-Alzheimer's dementia.
Raszewski G; Chwedorowicz R; Chwedorowicz A; Gustaw Rothenberg K
Ann Agric Environ Med; 2016; 23(1):193-6. PubMed ID: 27007541
[TBL] [Abstract][Full Text] [Related]
85. Do VDR Gene Polymorphisms Contribute to Breast Cancer?
Shaikh F; Baig S; Jamal Q
Asian Pac J Cancer Prev; 2016; 17(2):479-83. PubMed ID: 26925631
[TBL] [Abstract][Full Text] [Related]
86. The roles of UVB and vitamin D in reducing risk of cancer incidence and mortality: A review of the epidemiology, clinical trials, and mechanisms.
Moukayed M; Grant WB
Rev Endocr Metab Disord; 2017 Jun; 18(2):167-182. PubMed ID: 28213657
[TBL] [Abstract][Full Text] [Related]
87. Vitamin D, PTH, and calcium in relation to survival following prostate cancer.
Brändstedt J; Almquist M; Manjer J; Malm J
Cancer Causes Control; 2016 May; 27(5):669-77. PubMed ID: 27023469
[TBL] [Abstract][Full Text] [Related]
88. Vitamin D receptor expression and associated gene signature in tumour stromal fibroblasts predict clinical outcome in colorectal cancer.
Ferrer-Mayorga G; Gómez-López G; Barbáchano A; Fernández-Barral A; Peña C; Pisano DG; Cantero R; Rojo F; Muñoz A; Larriba MJ
Gut; 2017 Aug; 66(8):1449-1462. PubMed ID: 27053631
[TBL] [Abstract][Full Text] [Related]
89. Vitamin D and pancreas: The role of sunshine vitamin in the pathogenesis of diabetes mellitus and pancreatic cancer.
Altieri B; Grant WB; Della Casa S; Orio F; Pontecorvi A; Colao A; Sarno G; Muscogiuri G
Crit Rev Food Sci Nutr; 2017 Nov; 57(16):3472-3488. PubMed ID: 27030935
[TBL] [Abstract][Full Text] [Related]
90. Micronutrients in Oncological Intervention.
Gröber U; Holzhauer P; Kisters K; Holick MF; Adamietz IA
Nutrients; 2016 Mar; 8(3):163. PubMed ID: 26985904
[TBL] [Abstract][Full Text] [Related]
91. Serum Vitamin D is Not Helpful for Predicting Prostate Cancer Aggressiveness Compared with the Prostate Health Index.
Stephan C; Lein M; Matalon J; Kilic E; Zhao Z; Busch J; Jung K
J Urol; 2016 Sep; 196(3):709-14. PubMed ID: 26976204
[TBL] [Abstract][Full Text] [Related]
92. Calcium and Vitamin D for the Prevention of Colorectal Adenomas.
Mutneja H; Arora S; Vij A
N Engl J Med; 2016 Feb; 374(8):791. PubMed ID: 26933860
[No Abstract] [Full Text] [Related]
93. Vitamin D and Cancer Risk and Mortality: State of the Science, Gaps, and Challenges.
Mondul AM; Weinstein SJ; Layne TM; Albanes D
Epidemiol Rev; 2017 Jan; 39(1):28-48. PubMed ID: 28486651
[TBL] [Abstract][Full Text] [Related]
94. Impact of a tailored oral vitamin D supplementation regimen on serum 25-hydroxyvitamin D levels in early breast cancer patients: a randomized phase III study.
Jacot W; Firmin N; Roca L; Topart D; Gallet S; Durigova A; Mirr S; Abach L; Pouderoux S; D'Hondt V; Bleuse JP; Lamy PJ; Romieu G
Ann Oncol; 2016 Jul; 27(7):1235-41. PubMed ID: 27029707
[TBL] [Abstract][Full Text] [Related]
95. Population-wide Impact of Long-term Use of Aspirin and the Risk for Cancer.
Cao Y; Nishihara R; Wu K; Wang M; Ogino S; Willett WC; Spiegelman D; Fuchs CS; Giovannucci EL; Chan AT
JAMA Oncol; 2016 Jun; 2(6):762-9. PubMed ID: 26940135
[TBL] [Abstract][Full Text] [Related]
96. Management of bone loss in postmenopausal breast cancer patients treated with aromatase inhibitors.
Cepa M; Vaz C
Acta Reumatol Port; 2015; 40(4):323-30. PubMed ID: 26922195
[TBL] [Abstract][Full Text] [Related]
97. Plasma 25-Hydroxyvitamin D and Risk of Breast Cancer in Women Followed over 20 Years.
Eliassen AH; Warner ET; Rosner B; Collins LC; Beck AH; Quintana LM; Tamimi RM; Hankinson SE
Cancer Res; 2016 Sep; 76(18):5423-30. PubMed ID: 27530324
[TBL] [Abstract][Full Text] [Related]
98. Do studies reporting 'U'-shaped serum 25-hydroxyvitamin D-health outcome relationships reflect adverse effects?
Grant WB; Karras SN; Bischoff-Ferrari HA; Annweiler C; Boucher BJ; Juzeniene A; Garland CF; Holick MF
Dermatoendocrinol; 2016; 8(1):e1187349. PubMed ID: 27489574
[TBL] [Abstract][Full Text] [Related]
99. Serum Vitamin D and Prostate Cancer Prognosis: The Story Continues.
Roca E; Valcamonico F; Amoroso V; Antonelli A; Foroni C; Simeone C; Berruti A
J Clin Oncol; 2016 Oct; 34(30):3709-3710. PubMed ID: 27458304
[No Abstract] [Full Text] [Related]
100. Vitamin D and gonadal function in men: a potential inverse U-shaped association?
Karras S; Anagnostis P; Kotsa K; Goulis DG
Andrology; 2016 May; 4(3):542-4. PubMed ID: 26991835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
